Search research articles
Contact Us
Filters
Showing results (241-250 of 261) with videos related to
Page
of 27
Sort By:
Proteomics
|
October 18, 2011
Temporal proteomic profile of memory consolidation in the rat hippocampal dentate gyrus
Marco P Monopoli, Michelle Nic Raghnaill, Jennifer S Loscher, et al.
Seizure
|
August 11, 2020
Epilepsy, anti-seizure medication, intellectual disability and challenging behaviour - Everyone's business, no one's priority
M O Kinney, V Chester, S Tromans, et al.
Science Translational Medicine
|
April 28, 2012
Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism
Jill L Silverman, Daniel G Smith, Stacey J Sukoff Rizzo, et al.
Psychopharmacology
|
March 4, 2008
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders
Sarah K Leonard, Jason M Dwyer, Stacey J Sukoff Rizzo, et al.
Journal of Pharmacological and Toxicological Methods
|
January 6, 2009
Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse
Darrick T Balu, Georgia E Hodes, Tiffany E Hill, et al.
Psychopharmacology
|
September 20, 2013
Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives
Martien J Kas, Jeffrey C Glennon, Jan Buitelaar, et al.
Journal of Intellectual Disability Research : JIDR
|
August 10, 2019
The impact of an epilepsy nurse competency framework on the costs of supporting adults with epilepsy and intellectual disability: findings from the EpAID study
M Pennington, H Ring, J Howlett, et al.
Plos One
|
January 23, 2020
Fragmentation and inefficiencies in US equity markets: Evidence from the Dow 30
Brian F Tivnan, David Rushing Dewhurst, Colin M Van Oort, et al.
Scandinavian Journal of Gastroenterology
|
January 23, 1998
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
I Nordøy, H B Krarup, H Bell, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1999
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP)
H L Janssen, G Gerken, V Carreño, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 261) with videos related to
Sort By:
Page
of 27
Proteomics
|
October 18, 2011
Temporal proteomic profile of memory consolidation in the rat hippocampal dentate gyrus
Marco P Monopoli, Michelle Nic Raghnaill, Jennifer S Loscher, et al.
Seizure
|
August 11, 2020
Epilepsy, anti-seizure medication, intellectual disability and challenging behaviour - Everyone's business, no one's priority
M O Kinney, V Chester, S Tromans, et al.
Science Translational Medicine
|
April 28, 2012
Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism
Jill L Silverman, Daniel G Smith, Stacey J Sukoff Rizzo, et al.
Psychopharmacology
|
March 4, 2008
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders
Sarah K Leonard, Jason M Dwyer, Stacey J Sukoff Rizzo, et al.
Journal of Pharmacological and Toxicological Methods
|
January 6, 2009
Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse
Darrick T Balu, Georgia E Hodes, Tiffany E Hill, et al.
Psychopharmacology
|
September 20, 2013
Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives
Martien J Kas, Jeffrey C Glennon, Jan Buitelaar, et al.
Journal of Intellectual Disability Research : JIDR
|
August 10, 2019
The impact of an epilepsy nurse competency framework on the costs of supporting adults with epilepsy and intellectual disability: findings from the EpAID study
M Pennington, H Ring, J Howlett, et al.
Plos One
|
January 23, 2020
Fragmentation and inefficiencies in US equity markets: Evidence from the Dow 30
Brian F Tivnan, David Rushing Dewhurst, Colin M Van Oort, et al.
Scandinavian Journal of Gastroenterology
|
January 23, 1998
Interferon-alpha 2b therapy in low-activity hepatitis C: a pilot study
I Nordøy, H B Krarup, H Bell, et al.
Hepatology (Baltimore, Md.)
|
July 1, 1999
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP)
H L Janssen, G Gerken, V Carreño, et al.
Page
of 27